Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2020-03-23
Product name
Ceftibuten Capsules Formulation
supplier name
Merck & Co., Inc
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H332, H334
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
OSHA HCS Classification
Combustible dust Acute toxicity (Inhalation) Category 4 Respiratory sensitization Category 1
Signal word
Danger
Hazard statements
If small particles are generated during further processing, handling or by other means, may form combustible dust concentrations in air. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 Avoid breathing dust. P271 Use only outdoors or in a well-ventilated area. P285 In case of inadequate ventilation wear respiratory protec- tion.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin.
